Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury

J Spinal Cord Med. 2001 Spring;24(1):35-40. doi: 10.1080/10790268.2001.11753553.

Abstract

Objective: To assess the efficacy of sildenafil in men with spinal cord injury (SCI) and erectile dysfunction (ED).

Methods: Seventeen men with SCI were selected from February to September 1998 for sildenafil treatment of ED. The initial dose of 25 mg was increased by 25-mg increments as needed. Patients underwent baseline physical examination and answered questions from the abridged International Index of Erectile Function before and during therapy.

Results: Sixteen patients tolerated therapy; 1 developed hypotension and discontinued therapy. There was significant improvement in erectile function (P < .05) after 5.3 +/- 2.2 months when compared with baseline or previous therapies (P < .05). Of the 17 patients, 94% recommended sildenafil to others. Six of these 16 patients were available for long-term follow-up. There was further significant improvement in quality of erection (P < .05), but no change in satisfaction.

Conclusion: Sildenafil is effective and well tolerated in men with SCI and ED.

MeSH terms

  • Administration, Oral
  • Adult
  • Erectile Dysfunction / complications*
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use*
  • Purines
  • Sildenafil Citrate
  • Spinal Cord Injuries / complications*
  • Sulfones
  • Time Factors

Substances

  • Piperazines
  • Purines
  • Sulfones
  • Sildenafil Citrate